Illumina, Inc. (ILMN)

Illumina, Inc. (ILMN) is a healthcare company (diagnostics & research) based in the United States. The share price is $198.98, up 0.49% on the day, which values the company at $30.09B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.

Key facts

Share price
$198.98+0.49% today
Market value
$30.09B
P/E ratio
34.2×last 12 months
Forward P/E
32.2×
Funk Score
59/100
Against its own history
Below its usual priceusual price $282.76
200-week average
$142.4540% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Illumina, Inc. in more detail

ILMN trades at 34.2× its last twelve months' earnings, 32.2× next year's expected earnings, 6.6× sales. Measured against its own history, the price is 30% below what its usual multiples would imply ($282.76) — below its usual price. It sits 40% above its 200-week average of $142.45.

Its Funk Score is 59 out of 100 (financial strength 7.3, profitability 8.0, growth 2.4, value 6.0, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Revenue is shrinking.

11 of the superinvestors tracked here hold ILMN, including Keith Meister (15.5% of the portfolio), Richard Mashaal (6.3% of the portfolio), Zach Schreiber (2.7% of the portfolio).

Superinvestors holding ILMN

11 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:ILMN vs RMD (Illumina, Inc. vs ResMed)ILMN vs GMAB (Illumina, Inc. vs Genmab)ILMN vs ZTS (Illumina, Inc. vs Zoetis)ILMN vs CNC (Illumina, Inc. vs Centene)ILMN vs MTD (Illumina, Inc. vs Mettler-Toledo International)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Illumina, Inc. (ILMN): questions and answers

What is ILMN's P/E ratio?

Illumina, Inc. trades at 34.2× its last twelve months' earnings and 32.2× next year's expected earnings. At its fiscal year-ends over the past 15 years the P/E ranged from 24.1× to 122.9×, with a median of 53.9×.

What is ILMN's PEG ratio?

Illumina, Inc.'s PEG ratio is 2.55 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Illumina, Inc.'s market cap?

Illumina, Inc. is valued at $30.09B at a share price of $198.98.

Is ILMN overvalued or undervalued?

Against its own history, ILMN is below its usual price: the price is 30% below the $282.76 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ILMN above its 200-week moving average?

Yes. ILMN is 39.7% above its 200-week average of $142.45. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Illumina, Inc. growing?

Over the last three fiscal years Illumina, Inc.'s revenue grew -1.4% a year and its earnings per share 3.6% a year.

Cite this page

Funkfolio, “Illumina, Inc. (ILMN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ILMN

Underlying data: Yahoo Finance; company filings with the SEC.